# AffaMed Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/affamed-therapeutics

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.affamed.com/
- Total disclosed funding: $170M
- Latest round: Series B (Mar 30, 2021)
- Investors on record: 6

## About

Based in New York, US and founded in 2019, AffaMed Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital, and surgical products. The firm operates from locations in the US and China, In March 2021, AffaMed Therapeutics raised USD 170 million in Series B funding led by Lake Bleu Capital, with participation from Partners Investment, Superstring Capital, Orion Capital Management, and Fountainhead Partner.

## Funding rounds

- Series B, Mar 30, 2021, $170M — Partners Investment, CBC Group, Fountainhead Investment Partners, Orion Capital Management, Lake Bleu Capital, Superstring Capital Management

## Investors

- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series B
- CBC Group (https://capitalatlas.ai/funds/cbc-group) — Series B
- Fountainhead Investment Partners (https://capitalatlas.ai/funds/fountainhead-investment-partners) — Series B
- Orion Capital Management (https://capitalatlas.ai/funds/orion-capital-management) — Series B
- Lake Bleu Capital (https://capitalatlas.ai/funds/lake-bleu-capital) — Series B
- Superstring Capital Management (https://capitalatlas.ai/funds/superstring-capital-management) — Series B